Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Current and Future Perspectives of PDL1 PET and SPECT Imaging - ScienceDirect,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Revisiting the PD-1 pathway | Science Advances